• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Stem Cell Reports . SARS-CoV-2 tropism to intestinal but not gastric epithelial cells is defined by limited ACE2 expression

tetano

Editor, Senior Moderator
Stem Cell Reports


. 2024 Apr 21:S2213-6711(24)00083-3.
doi: 10.1016/j.stemcr.2024.03.008. Online ahead of print. SARS-CoV-2 tropism to intestinal but not gastric epithelial cells is defined by limited ACE2 expression

Mindaugas Paužuolis[SUP] 1 [/SUP], Diana Fatykhova[SUP] 2 [/SUP], Boris Zühlke[SUP] 3 [/SUP], Torsten Schwecke[SUP] 4 [/SUP], Mastura Neyazi[SUP] 1 [/SUP], Pilar Samperio-Ventayol[SUP] 5 [/SUP], Carmen Aguilar[SUP] 1 [/SUP], Nicolas Schlegel[SUP] 6 [/SUP], Simon Dökel[SUP] 7 [/SUP], Markus Ralser[SUP] 8 [/SUP], Andreas Hocke[SUP] 3 [/SUP], Christine Krempl[SUP] 9 [/SUP], Sina Bartfeld[SUP] 10 [/SUP]



Affiliations
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection primarily affects the lung but can also cause gastrointestinal (GI) symptoms. In vitro experiments confirmed that SARS-CoV-2 robustly infects intestinal epithelium. However, data on infection of adult gastric epithelium are sparse and a side-by-side comparison of the infection in the major segments of the GI tract is lacking. We provide this direct comparison in organoid-derived monolayers and demonstrate that SARS-CoV-2 robustly infects intestinal epithelium, while gastric epithelium is resistant to infection. RNA sequencing and proteome analysis pointed to angiotensin-converting enzyme 2 (ACE2) as a critical factor, and, indeed, ectopic expression of ACE2 increased susceptibility of gastric organoid-derived monolayers to SARS-CoV-2. ACE2 expression pattern in GI biopsies of patients mirrors SARS-CoV-2 infection levels in monolayers. Thus, local ACE2 expression limits SARS-CoV-2 expression in the GI tract to the intestine, suggesting that the intestine, but not the stomach, is likely to be important in viral replication and possibly transmission.

Keywords: ACE2; SARS-CoV-2; gastrointestinal epithelium; infection model; intestine; organoids; stomach.

 
Back
Top Bottom